Results 151 to 160 of about 19,485 (207)

Retrospective, Multicenter Study of Lacosamide to Treat Neonatal Seizures

Annals of the Child Neurology Society, Volume 4, Issue 1, Page 52-63, March 2026.
ABSTRACT Objective Most antiseizure medications (ASMs) are prescribed off label for neonates. Lacosamide's efficacy in infants and availability in intravenous formulation suggest potential utility for neonates. We evaluated the safety and efficacy of lacosamide for neonatal seizures. Methods This 10‐center, retrospective study of neonates with seizures
Alexandra Santana Almansa, Jessica R. Landers, Nicholas S. Abend, Giulia M. Benedetti, Catherine J. Chu, Andrew T. Knox, Shavonne Massey, Steffany Moen, Andrea C. Pardo, Arnold Sansevere, Renée A. Shellhaas, Cameron Thomas, Tammy Tsuchida, Sonya Wang, Bo Zhang, Janet S. Soul   +15 more
wiley   +1 more source

Pharmacotherapy for Alcohol Craving Reduction: Efficacy of Short-Term Treatments in Alcohol Use Disorder. [PDF]

Medicines (Basel)
Cheibub David Marin M, Pozzolo Pedro MO, Perrotte G, Castaldelli-Maia JM.   +3 more
europepmc   +1 more source

Obesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions

Food Science &Nutrition, Volume 14, Issue 3, March 2026.
Natural products such as EGCG, berberine, curcumin, and capsaicin modulate key metabolic pathways including AMPK activation, adipogenesis inhibition, and inflammatory signaling. While clinical trials demonstrate modest benefits on body weight and metabolic parameters, translational challenges related to bioavailability, dose feasibility, and regulatory
Ohoud M. Marie, Abdelghafar Abu‐Elsaoud   +1 more
wiley   +1 more source

Persistent genital arousal symptoms in a young woman with recurring brief psychoses: a clinical dilemma in antipsychotic choice. [PDF]

J Psychiatry Neurosci
Fortin-Latour É, Stip E.
europepmc   +1 more source

Anticonvulsant Therapy in Trigeminal Neuralgia: A Class-Oriented Systematic Review. [PDF]

Medicines (Basel)
Pinto Moreira M, Carneiro BD, Faria CS, Pozza DH, Fonseca S.   +4 more
europepmc   +1 more source

When Recurrent Pancreatitis Is Not Pancreatitis: Cyclic Vomiting Syndrome Masquerading as Acute Pancreatitis in a Young Adult. [PDF]

Cureus
Ottu Para NK, Kalakappara S, Abubacker MTM.   +2 more
europepmc   +1 more source

Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden

Addiction, Volume 121, Issue 3, Page 597-605, March 2026.
Abstract Aim To examine the socioeconomic differences in the effectiveness of alcohol use disorders (AUD) pharmacotherapy and risk of AUD hospitalisation. Design A prospective register‐based cohort study. Setting Sweden. Participants Individuals who were registered as living in Sweden in 2005 (16–64 years) with a first‐time AUD diagnosis and complete ...
Devy L. Elling, Emelie Thern, Lluís Mangot‐Sala, Jari Tiihonen, Anders Hammarberg, Daniel Falkstedt, Heidi Taipale   +6 more
wiley   +1 more source

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER)

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2403-2415, March 2026.
Abstract Aims To assess the real‐world effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in an insured US population.
Lauren Wilson, Zhenxiang Zhao, Victoria Divino, Matthew Bassan, Bríain Ó. Hartaigh, Signe Stensen, Kerem Ozer   +6 more
wiley   +1 more source

Medical Management of Obesity: A Comprehensive Review of Food and Drug Administration (FDA)-Approved and Investigational Therapies. [PDF]

Cureus
Raza SS, Zakir Z, Hashmat A, Awan SK, Varrassi G.   +4 more
europepmc   +1 more source

Predominant Symptom in Gastroparesis: Relationships to Quality of Life, Treatments, and Outcome

Neurogastroenterology &Motility, Volume 38, Issue 3, March 2026.
In patients with gastroparesis, the most common predominant symptoms were nausea, vomiting, and abdominal pain. Impaired QOL varied with patients' predominant symptom, with abdominal pain associated with poorer QOL. Over 48 weeks, GSCI improved ≥ 1 in a minority of patients, more often in patients with predominant symptoms of nausea and bloating, less ...
Henry P. Parkman, Laura A. Wilson, William L. Hasler, Madhusudan Grover, Bruno P. Chumpitazi, Helen Burton‐Murray, Irene Sarosiek, Baha Moshiree, Geoffrey A. Preidis, Robert J. Shulman, Laura A. Miriel, Dave Shade, Braden Kuo, Richard W. McCallum, Thomas L. Abell, Pankaj J. Pasricha, for the NIDDK Gastroparesis Clinical Research Consortium   +16 more
wiley   +1 more source